Literature DB >> 15722110

RPE65 gene mutation prevents development of autofluorescence in retinal pigment epithelial phagosomes.

Martin L Katz1, Kristy D Wendt, Douglas N Sanders.   

Abstract

During senescence, autofluorescent lysosomal storage bodies known as lipofusin or age pigment accumulate in many post-mitotic types of cells. Among these cell types is the retinal pigment epithelium (RPE) of the mammalian eye. The mechanisms of lipofuscin formation and accumulation have been studied more extensively in the RPE than in any other cell type. Substantial evidence indicates that Vitamin A derivatives (retinoids) are required for RPE lipofuscin formation. The RPE and adjacent retina contain retinoids in the forms of retinol, retinyl esters, and retinaldehyde. Previous research has demonstrated that retinaldehydes are directly involved in the formation of one RPE lipofuscin fluorophore. However, RPE lipofuscin contains many other fluorophores. It has not been determined which retinoids are involved in the formation of these fluorescent compounds. Mice with a mutation in the Rpe65 gene contain substantial levels of retinol and retinyl esters in the RPE, but little if any retinaldehydes in either the RPE or retina. Therefore, these mice could be used to determine whether retinaldehydes are required for formation of all of the RPE lipofuscin fluorophores. Normal mice were given intraocular injections of a protease inhibitor, which resulted in the rapid accumulation in the RPE of lipofuscin-like inclusions. These inclusions exhibited fluorescence properties typical of RPE lipofuscin. Rpe65-/- mice treated with the protease inhibitor also accumulated inclusions similar to those observed in the normal mice. However, these inclusions did not fluoresce under the conditions used to visualize lipofuscin fluorescence. These findings indicate that the aldehyde form of Vitamin A is required for the formation of not only one, but all of the RPE lipofuscin fluorophores.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15722110     DOI: 10.1016/j.mad.2004.11.004

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  9 in total

1.  Histopathology and functional correlations in a patient with a mutation in RPE65, the gene for retinol isomerase.

Authors:  Vera L Bonilha; Mary E Rayborn; Yong Li; Gregory H Grossman; Eliot L Berson; Joe G Hollyfield
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-28       Impact factor: 4.799

2.  Ocular phenotype in a mouse gene knockout model for infantile neuronal ceroid lipofuscinosis.

Authors:  Bo Lei; Gregory E Tullis; Mark D Kirk; Keqing Zhang; Martin L Katz
Journal:  J Neurosci Res       Date:  2006-10       Impact factor: 4.164

3.  Ultrastructural Changes and Expression of PCNA and RPE65 in Sodium Iodate-Induced Acute Retinal Pigment Epithelium Degeneration Model.

Authors:  Hong-Lim Kim; Sung Min Nam; Byung-Joon Chang; Sang-Soep Nahm; Jong-Hwan Lee
Journal:  Neurochem Res       Date:  2018-03-22       Impact factor: 3.996

4.  Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival.

Authors:  Danhong Zhu; Xuemei Deng; Christine Spee; Shozo Sonoda; Chih-Lin Hsieh; Ernesto Barron; Martin Pera; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

5.  Fundus autofluorescence in children and teenagers with hereditary retinal diseases.

Authors:  Bettina Wabbels; Anke Demmler; Karina Paunescu; Erika Wegscheider; Markus N Preising; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-21       Impact factor: 3.117

6.  Intrinsic tissue fluorescence in an organotypic perfusion culture of the porcine ocular fundus exposed to blue light and free radicals.

Authors:  Martin Hammer; Sandra Richter; Karin Kobuch; Nathan Mata; Dietrich Schweitzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-20       Impact factor: 3.117

7.  Retinal Gene Therapy: Current Progress and Future Prospects.

Authors:  Cristy A Ku; Mark E Pennesi
Journal:  Expert Rev Ophthalmol       Date:  2015-04-10

8.  Characterization of neurological disease progression in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Elizabeth J Meiman; Grace Robinson Kick; Cheryl A Jensen; Joan R Coates; Martin L Katz
Journal:  Dev Neurobiol       Date:  2022-04-28       Impact factor: 3.102

9.  Visual system pathology in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Grace Robinson Kick; Elizabeth J Meiman; Julianna C Sabol; Rebecca E H Whiting; Juri Ota-Kuroki; Leilani J Castaner; Cheryl A Jensen; Martin L Katz
Journal:  Exp Eye Res       Date:  2021-06-30       Impact factor: 3.770

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.